{"id":"W4255585525","doi":"10.1200/jco.2012.30.15_suppl.lba10008","title":"Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Regorafenib; Medicine; Sunitinib; GiST; Imatinib; Internal medicine; Oncology; Randomized controlled trial; Stromal tumor; Clinical trial; Stromal cell; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009318806,0.001308818,0.001622097,0.000208293,0.0002546733,0.0007604561,0.0007280029,0.000957849,0.008241798],"category_scores_gemma":[0.001082456,0.0003690643,0.001062137,0.0003209732,0.0007840953,0.0009369538,0.0004753515,0.002203885,0.001807081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008335078,"about_ca_system_score_gemma":0.00107082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001655349,"about_ca_topic_score_gemma":0.006343161,"domain_scores_codex":[0.9997045,0.0001608067,0.00001199523,0.00005214011,0.0000191712,0.00005127827],"domain_scores_gemma":[0.9995595,0.00007490224,0.0001188864,0.00005161917,0.00002016716,0.0001749837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9121917,0.003932907,0.002504611,0.0008960124,0.001427788,0.0001674909,0.00009905608,0.002146555,0.00409563,0.000603331,0.01669388,0.05524108],"study_design_scores_gemma":[0.9673546,0.02336574,0.003404372,0.00003748753,0.0002747232,0.0001614843,0.00004704188,0.0005614787,0.0002556278,0.0005573056,0.003964412,0.00001570069],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616362,0.00989993,0.001137997,0.003449727,0.001244794,0.003416984,0.007517462,0.000494119,0.01120271],"genre_scores_gemma":[0.97017,0.004052401,0.002618139,0.00328863,0.0004035018,0.004418849,0.007056668,0.00007137611,0.007920349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008241798,"threshold_uncertainty_score":0.02757156,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1390128879229256,"score_gpt":0.4586018462701245,"score_spread":0.3195889583471989,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}